Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s loss per share is pinned at 20 cents. In the absence of a marketed product, ...
NRx Pharmaceuticals (NASDAQ:NRXP) stock rallied 35% Monday after its subsidiary HOPE Therapeutics announced the signing of a binding term sheet with Smith & Sauer for $25M in equity purchases to fund ...
On Match 21st NRXP announced the results of a Special Meeting of Shareholders giving the Board of Directors authority to effect a reverse stock split of all of the outstanding shares of NRXP stock in ...
We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. NRx Pharmaceuticals, Inc. is one of them. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical ...
On Match 21st NRXP announced the results of a Special Meeting of Shareholders giving the Board of Directors authority to effect a reverse stock split of all of the outstanding shares of NRXP stock in ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) stands against the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results